Keyphrases
Randomized Controlled Trial
100%
End-stage Liver Disease
100%
Ischemia-free Liver Transplantation
100%
Ischemia-reperfusion Injury
60%
Liver Transplantation
50%
Organ Transplantation
30%
Organ Availability
20%
Early Allograft Dysfunction
20%
Liver
10%
Ischemia
10%
Improved Outcomes
10%
Randomized Trial
10%
Transplantation
10%
Group Differences
10%
Organ Damage
10%
Clinical Model
10%
Donor Liver
10%
Blood Supply
10%
Transplant Outcomes
10%
Randomized Controlled Clinical Trial
10%
Organ Utilization
10%
Alloimmunization
10%
Magnetic Resonance Cholangiopancreatography
10%
AIMS™
10%
Graft Ischemia
10%
Donation after Brain Death
10%
Non-anastomotic Strictures
10%
Reperfusion Syndrome
10%
Comprehensive Complication Index
10%
Medicine and Dentistry
Randomized Controlled Trial
100%
Liver Transplantation
100%
Ischemia
100%
End Stage Liver Disease
100%
Reperfusion Injury
42%
Organ Transplantation
28%
Transplantation
21%
Allograft
14%
Vascularity
7%
Cholestasis
7%
Alloimmunity
7%
Controlled Clinical Trial
7%
Organ Injury
7%
Magnetic Resonance Cholangiopancreatography
7%
Brain Death
7%
Pharmacology, Toxicology and Pharmaceutical Science
Ischemia
100%
Randomized Controlled Trial
100%
End Stage Liver Disease
100%
Reperfusion Injury
54%
Controlled Clinical Trial
9%
Syndrome
9%
Cholestasis
9%
Organ Injury
9%
Brain Death
9%
Biochemistry, Genetics and Molecular Biology
Reperfusion
100%
Randomized Controlled Trial
100%
Magnetism
14%
Vascularization
14%
Alloimmunity
14%
Controlled Clinical Trial
14%
Immunology and Microbiology
Liver Transplantation
100%
Reperfusion
50%
Organ Transplantation
28%
Allograft
14%
Magnetism
7%
Alloimmunity
7%
Vascularization
7%